Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 5/20 | 0.50 |
| ▸ | FNTB | P49356 | 5/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3359833 | 1.00 | FNTA (0.50) | FNTAFNTBGRIK1GRIK2KDM4E | |
| SCHEMBL3359834 | 1.00 | FNTA (0.50) | FNTAFNTBGRIK1GRIK2KDM4E | |
| SCHEMBL11475484 | 0.86 | FNTA (0.41) | FNTAFNTBGRIK1GRIK2TSHR | |
| SCHEMBL3092195 | 0.85 | FNTA (0.63) | FNTAFNTBGRIK1GRIK2KDM4E | |
| SCHEMBL13287281 | 0.81 | FNTA (0.38) | FNTAFNTBGRIK1GRIK2ALDH1A1 | |
| SCHEMBL24901145 | 0.79 | FNTA (0.37) | FNTAFNTBGRIK1GRIK2 | |
| SCHEMBL28174784 | 0.79 | GRIK1 (0.41) | FNTAFNTBGRIK1GRIK2TBXAS1 | |
| SCHEMBL11774659 | 0.78 | CYP2D6 (0.40) | FNTAFNTBGRIK1GRIK2ALDH1A1 | |
| Acetic Acid SCHEMBL592036 | 0.76 | GRIK1 (0.40) | FNTAFNTBGRIK1GRIK2KDM4E | |
| SCHEMBL8134708 | 0.75 | GRIK1 (0.47) | FNTAFNTBGRIK1GRIK2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2362765-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2011-09-07 | — | — | EP | claimed |
| WO-2010065446-A2 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2010-06-10 | — | — | WO | claimed |
| US-20100137178-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2010-06-03 | — | — | US | claimed |
| CN-113527079-B | Method for preparing 2-isopropenyl-5-methyl-4-hexenoic acid and derivative alcohol and carboxylic ester thereof | 信越化学工业株式会社 | 2023-11-14 | — | — | CN | disclosed |
| EP-3901125-B1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | SHINETSU CHEMICAL CO (JP) | 2023-01-18 | — | — | EP | disclosed |
| US-11286227-B2 | Processes for preparing 2-isopropenyl-5-methyl-4-hexenoic acid, 2-isopropenyl-5-methyl-4-hexen-1-ol, and a carboxylate ester thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-03-29 | — | — | US | disclosed |
| EP-3901125-A1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-10-27 | — | — | EP | disclosed |
| CN-113527079-A | Method for preparing 2-isopropenyl-5-methyl-4-hexenoic acid and derivative alcohol and carboxylic ester thereof | 信越化学工业株式会社 | 2021-10-22 | — | — | CN | disclosed |
| US-20210323902-A1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-10-21 | — | — | US | disclosed |
| EP-2362765-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2020-04-08 | — | — | EP | disclosed |
| US-8431520-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2013-04-30 | — | — | US | disclosed |
| US-20130012422-A1 | PERFUME SYSTEMS | SMETS JOHAN (BE) | 2013-01-10 | — | — | US | disclosed |
| US-20100137178-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323902-A1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | IGF1R, HPD, IGF2R | FNTA 2364/4885FNTB 3078/4885GRIK1 13/4885 |
| US-20130012422-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | FNTA 3984/4885FNTB 4328/4885GRIK1 3842/4885 |
| US-20100137178-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | FNTA 3984/4885FNTB 4328/4885GRIK1 3842/4885 |
| US-11286227-B2 | Processes for preparing 2-isopropenyl-5-methyl-4-hexenoic acid, 2-isopropenyl-5-methyl-4-hexen-1-ol, and a carboxylate ester thereof | IGF1R, HPD, IGF2R | FNTA 2364/4885FNTB 3078/4885GRIK1 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.